Left ventricular dysfunction in COPD without pulmonary hypertension

PloS One
Janne M HildeKjetil Steine

Abstract

We aimed to assess prevalence of left ventricular (LV) systolic and diastolic function in stable cohort of COPD patients, where LV disease had been thoroughly excluded in advance. 100 COPD outpatients in GOLD II-IV and 34 controls were included. Patients were divided by invasive mean pulmonary artery pressure (mPAP) in COPD-PH (≥25 mmHg) and COPD-non-PH (<25 mmHg), which was subdivided in mPAP ≤20 mmHg and 21-24 mmHg. LV myocardial performance index (LV MPI) and strain by tissue Doppler imaging (TDI) were used for evaluation of LV global and systolic function, respectively. LV MPI ≥0.51 and strain ≤-15.8% were considered abnormal. LV diastolic function was assessed by the ratio between peak early (E) and late (A) velocity, early TDI E´, E/E´, isovolumic relaxation time, and left atrium volume. LV MPI ≥0.51 was found in 64.9% and 88.5% and LV strain ≤-15.8% in 62.2.% and 76.9% in the COPD-non-PH and COPD-PH patients, respectively. Similarly, LV MPI and LV strain were impaired even in patients with mPAP <20 mmHg. In multiple regression analyses, residual volume and stroke volume were best associated to LV MPI and LV strain, respectively. Except for isovolumic relaxation time, standard diastolic echo indices as E/A, E´, E/E´ and l...Continue Reading

References

Mar 1, 1980·Circulation·J A BrinkerM L Weisfeldt
Aug 10, 2000·American Journal of Respiratory and Critical Care Medicine·A BoussugesJ Orehek
May 10, 2002·The European Respiratory Journal·S SantosJ A Barberà
Aug 9, 2005·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Remzi YilmazRecep Demirbag
Apr 12, 2007·Chest·Barbara LichodziejewskaDanuta Liszewska-Pfejfer
May 18, 2007·American Journal of Respiratory and Critical Care Medicine·Klaus F RabeUNKNOWN Global Initiative for Chronic Obstructive Lung Disease
Mar 10, 2009·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Sherif F NaguehArturo Evangelisa
Jan 22, 2010·The New England Journal of Medicine·R Graham BarrKarol E Watson
Jan 22, 2010·The New England Journal of Medicine·Anton Vonk-Noordegraaf
Feb 27, 2010·Respiratory Medicine·Ramsey SabitDennis J Shale
Jun 28, 2011·The European Respiratory Journal·A MacchiaG Tognoni
Sep 29, 2012·The European Respiratory Journal·Xavier FreixaUNKNOWN PAC-COPD Study Investigators
Jul 9, 2013·Journal of the American College of Cardiology·Janne Mykland HildeKjetil Steine
Apr 22, 2016·International Journal of Chronic Obstructive Pulmonary Disease·Yoshiaki KubotaWataru Shimizu

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques
ELISA

Software Mentioned

TomTec

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.